KLK3 and prostate carcinoma: In 2012, it was estimated that the harms of annual PSA screening would be the overdiagnosis and overtreatment of 45 cases and the loss of 1134 life-years free of prostate cancer (lead time years) over the lifetime of 1000 men.8